He Xiao

State Key Laboratory Of Toxicology And Medical Countermeasures
Beijing, 100850, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Genome-wide meta-analysis with 1,590,596 individuals identifies 12 novel risk loci for systemic lupus erythematosus.

Genome-wide meta-analysis with 1,590,596 individuals identifies 12 novel risk loci for systemic lupus erythematosus.

Journal: Mammalian genome : official journal of the International Mammalian Genome Society
Published: March 10, 2026

Genome-Wide Meta-Analysis of 1 896 991 Individuals Identifies 31 Novel Risk Loci for Iron Deficiency Anemia.

Genome-Wide Meta-Analysis of 1 896 991 Individuals Identifies 31 Novel Risk Loci for Iron Deficiency Anemia.

Journal: European journal of haematology
Published: October 29, 2025

Rapamycin Treatment Alleviates Chronic GVHD-Induced Lupus Nephritis in Mice by Recovering IL-2 Production and Regulatory T Cells While Inhibiting Effector T Cells Activation.

Rapamycin Treatment Alleviates Chronic GVHD-Induced Lupus Nephritis in Mice by Recovering IL-2 Production and Regulatory T Cells While Inhibiting Effector T Cells Activation.

Journal: Biomedicines
Published: February 01, 2023

B cells regulate thymic CD8+T cell differentiation in lupus-prone mice.

B cells regulate thymic CD8+T cell differentiation in lupus-prone mice.

Journal: Oncotarget
Published: February 17, 2017

B cell activating factor (BAFF) selects IL-10-B cells over IL-10+B cells during inflammatory responses.

B cell activating factor (BAFF) selects IL-10-B cells over IL-10+B cells during inflammatory responses.

Journal: Molecular immunology
Published: September 17, 2016

Anti‑IL‑39 (IL‑23p19/Ebi3) polyclonal antibodies ameliorate autoimmune symptoms in lupus‑like mice.

Anti‑IL‑39 (IL‑23p19/Ebi3) polyclonal antibodies ameliorate autoimmune symptoms in lupus‑like mice.

Journal: Molecular medicine reports
Published: July 06, 2016

Foxd3 suppresses interleukin-10 expression in B cells.

Foxd3 suppresses interleukin-10 expression in B cells.

Journal: Immunology
Published: June 25, 2016

Pre-existing CD19-independent GL7(-) Breg cells are expanded during inflammation and in mice with lupus-like disease.

Pre-existing CD19-independent GL7(-) Breg cells are expanded during inflammation and in mice with lupus-like disease.

Journal: Molecular immunology
Published: October 14, 2015

A novel IL-23p19/Ebi3 (IL-39) cytokine mediates inflammation in Lupus-like mice.

A novel IL-23p19/Ebi3 (IL-39) cytokine mediates inflammation in Lupus-like mice.

Journal: European journal of immunology
Published: September 29, 2015

Ligation of metabotropic glutamate receptor 3 (Grm3) ameliorates lupus-like disease by reducing B cells.

Ligation of metabotropic glutamate receptor 3 (Grm3) ameliorates lupus-like disease by reducing B cells.

Journal: Clinical immunology (Orlando, Fla.)
Published: March 20, 2015

Blockade of B-cell activating factor with TACI-IgG effectively reduced Th1 and Th17 cells but not memory T cells in experimental allergic encephalomyelitis mice.

Blockade of B-cell activating factor with TACI-IgG effectively reduced Th1 and Th17 cells but not memory T cells in experimental allergic encephalomyelitis mice.

Journal: Central-European journal of immunology
Published: March 07, 2015

BAFF suppresses IL-15 expression in B cells.

BAFF suppresses IL-15 expression in B cells.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: March 28, 2014
Showing 1-12 of 13

Last Updated: 09/26/2026